Product Program year 2022 Source: CMS Open Payments

lidocaine

Drug Contraception

Open in the dashboard

General payments

$9,535

10 payments

Research payments

$0

0 payments

Through program year 2022, $9,535 in general payments and $0 in research payments were reported against lidocaine (Contraception).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $9,535 10

Breakdown

Who paid General payments · program year 2022
  1. Afaxys, Inc. $9,535 10 payments
Top recipients General payments · program year 2022
  1. Antoinette Marengo Barbick Obstetrics & Gynecology · San Diego, CA $1,258 13% · 2 payments
  2. Mark Hathaway Obstetrics & Gynecology · Washington, DC $1,225 13% · 1 payment
  3. Deborah Nucatola Obstetrics & Gynecology · Los Angeles, CA $1,225 13% · 1 payment
  4. Sarah Traxler Obstetrics & Gynecology · Saint Paul, MN $1,225 13% · 1 payment
  5. Scott Spear Adolescent Medicine · Edinburg, TX $1,225 13% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Obstetrics & Gynecology $6,158 65% · 5 practitioners
  2. Adolescent Medicine Pediatrics $1,225 13% · 1 practitioner
  3. Nurse Practitioner, Adult Health Nurse Practitioner $1,050 11% · 1 practitioner
  4. Nurse Practitioner, Women's Health Nurse Practitioner $1,050 11% · 1 practitioner
  5. Family Medicine $52 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. California $2,535 27% · 3 recipients
  2. Texas $2,275 24% · 2 recipients
  3. Florida $1,225 13% · 1 recipient
  4. Minnesota $1,225 13% · 1 recipient
  5. District of Columbia $1,225 13% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

1,571,615

Prescriptions dispensed, refills included

Drug cost

$158,113,674

Paid at the pharmacy, in all

Medicare Part D drugs matched to lidocaine, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Lidocaine Same name 36,357 1,067,217 $107,601,518
Ztlido Lidocaine Same name 1,585 65,727 $41,413,433
Lidocaine-Prilocaine Lidocaine/Prilocaine Similar name 9,958 247,633 $4,556,154
Lidocaine Hcl Viscous Lidocaine Hcl Similar name 5,373 104,908 $1,787,373
Dermacinrx Lidocan Lidocaine Same name 27 678 $1,571,730
Lidocaine Hcl Similar name 2,582 66,631 $704,393
Lidocaine Hcl Lidocaine Hcl/Pf Similar name 809 18,640 $188,602
Lidocan Iii Lidocaine Same name 4 89 $177,174
Lidoderm Lidocaine Same name 7 92 $113,297

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 586 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
John Kim Internal Medicine VA 1,888 $732,884 None on record
Joo Jang Nurse Practitioner NJ 1,852 $592,804 None on record
Tran Tran General Practice CA 1,700 $154,391 None on record
Young Kang Internal Medicine GA 1,669 $561,004 None on record
Juli Kang Nurse Practitioner NJ 1,620 $501,116 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 586 with Patron
10 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record